How Can We Help You?

Go To Home PageBack

Bladder Cancer Trials

Select Clinical Trial

CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

  • Men or women, ages 18 and older, diagnosed with advanced urinary tract (renal pelvis, ureter, bladder, prostate, or urethra) cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.




Clara McLean House
Make a Donation
News & Events